Total Clarity Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Total Clarity Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,462	Closed	-$300K	–	342
2025 Q4	$300K	Buy	+2,462	New	+$282K	0.07%	234
2022 Q3	–	Sell	-24	Closed	-$2K	–	983
2022 Q2	$2K	Buy	+24	New	+$1.8K	﹤0.01%	947
2022 Q1	–	Sell	-39	Closed	-$4K	–	922
2021 Q4	$4K	Buy	39 +2	+5%	+$241	﹤0.01%	858
2021 Q3	$5K	Buy	+37	New	+$4.76K	﹤0.01%	826
2021 Q2	–	Sell	-71	Closed	-$10K	–	753
2021 Q1	$10K	Buy	+71	New	+$10.6K	0.01%	569
2020 Q1	–	Sell	-47	Closed	-$4K	–	633
2019 Q4	$4K	Buy	+47	New	+$4.07K	﹤0.01%	620

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Total Clarity Wealth Management's XBI Position: Q1 2026 in Review

Total Clarity Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 2,462 shares — an estimated $300K sold.

Total Clarity Wealth Management first reported a position in XBI in Q4 2019 and held it in 6 quarters. The position peaked at $300K in Q4 2025. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Total Clarity Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
Total Clarity Wealth Management sold 2,462 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $300K.
Total Clarity Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 6 quarters.
Total Clarity Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $300K in Q4 2025.
816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Total Clarity Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.